Ticlopidine and its use in therapy
Nechifor, M.
Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 96(1-2): 39-40
1992
ISSN/ISBN: 0048-7848 PMID: 1410922 Document Number: 388522
Document emailed within 1 workday
Related Documents
Schneider, A.W.; Fechler, L.; Gilfrich, H.J. 1996: Ticlopidine-induced pancytopenia: therapy of agranulocytosis with granulocyte colony stimulating factor Medizinische Klinik 91(6): 417-419Kirichenko, A.A.; Mantserova, O.A.; Lebedeva, A.I.; D'iachkova, N.V.; Voloshina, N.M.; Mazurov, V.I.; Nifontov, V.M.; Tyrenko, V.V.; Kolina, I.G.; Cherkashina, A.L.; Shkodina, N.V.; Mazalov, K.V.; Spiropulos, N.A.; Eremenko, I.A.; Kuzin, A.I. 2007: Unstable angina: efficacy and tolerability of therapy with aspirin and aspirin combined with ticlopidine Kardiologiia 47(5): 24-27
Tohgi, H. 2006: Ticlopidine Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 7): 570-575
Villaverde, C.; Cánovas, M.; Padró, T.; Navarro, C. 1984: Ticlopidine as something more than a platelet antiaggregant Archivos de Farmacologia y Toxicologia 10(2): 121-132
Bruguera, M. 1997: Cholestatic hepatitis associated with ticlopidine Gastroenterologia y Hepatologia 20(3): 163-164
Lecompte, T.; Lecrubier, C.; Potevin, F.; Samama, M. 1986: Ticlopidine and platelet function Thrombosis and Haemostasis 55(3): 437-438
Marmont, A.M.; Lotti, G.; Nati, S.; Martinengo, M.; Morgano, A. 1985: Agranulocytosis caused by ticlopidine Recenti Progressi in Medicina 76(5): 245-248
Brigot, C.; Courillon-Mallet, A.; Roucayrol, A.M.; Cattan, D. 1998: Lymphocytic colitis and ticlopidine Gastroenterologie Clinique et Biologique 22(3): 361-362
Chen, L.K.; Hsieh, B.H.; Chen, W.C.; Tsai, S.T.; Hou, M.C. 2001: Ticlopidine-induced hepatitis Zhonghua Yi Xue Za Zhi 64(1): 59-63
Caliendo, G.; Bradbury, K.; Mehl, B. 1994: Ticlopidine, bleeding, and surgery Mount Sinai Journal of Medicine new York 61(4): 372-373
McCullough, P.A.; Marks, K.R. 1999: Ticlopidine and TTP after coronary stenting JAMA 282(18): 1717-8; author reply 1718-9
Domínguez, J.C.; Nieto, P.; Guerra, F.; Beltrán, C.; Molina, T.; Hidalgo, M.L.; Martín, E.; Martínez, M.C.; Cano, M. 1995: Use of ticlopidine in primary care Atencion Primaria 16(3): 137-140
Sánchez Ayuso, J.; Fernández González, F.; Fernández Rodríguez, E. 1997: Ticlopidine and bone marrow aplasia Medicina Clinica 109(16): 649
Porter, T.; Leibovittz, E.; Berliner, S. 1995: Ticlopidine in coronary artery diseases Harefuah 129(10): 427-430
Yoder, J.D.; Algozzine, G.J.; Hill, G.W. 1994: More ticlopidine-induced cholestatic jaundice American Journal of Hospital Pharmacy 51(14): 1821-1822
Lesesve, J.F.; Noblet, C.; Stamatoullas, A.; Gueit, I.; Moore, N.; Monconduit, M. 1995: Adverse hematologic effects of ticlopidine Therapie 50(5): 468-470
Varvello, L.; Arnò, C.; Coggiola, M.; Ramassotto, E.; Pascale, C. 2002: Cholestasis from ticlopidine: two clinical cases Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 17(4): 252-255
Day, H.J. 1984: Overview: clinical experiences with ticlopidine Agents and Actions. Supplements 15: 297-309
Panak, E.; Blanchard, J.; Roe, R.L. 1984: Evaluation of the antithrombotic efficacy of ticlopidine in man Agents and Actions. Supplements 15: 148-166
Hsu, V.D. 1993: Criteria for use of ticlopidine in adult inpatients and outpatients Clinical Pharmacy 12(1): 64-66